MCID: STR001
MIFTS: 34

Striatonigral Degeneration

Categories: Neuronal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Striatonigral Degeneration

MalaCards integrated aliases for Striatonigral Degeneration:

Name: Striatonigral Degeneration 12 50 51 41 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:4751
ICD10 32 G23.2
MeSH 41 D020955
SNOMED-CT 64 29618004
UMLS 69 C0270733

Summaries for Striatonigral Degeneration

NINDS : 50 Striatonigral degeneration is a neurological disorder caused by a disruption in the connection between two areas of the brain-the striatum and the substantia nigra. These two areas work together to enable balance and movement. Striatonigral degeneration is a type of multiple system atrophy (MSA). Symptoms of the disorder resemble some of those seen in Parkinson's disease, including rigidity, instability, impaired speech, and slow movements.

MalaCards based summary : Striatonigral Degeneration is related to multiple system atrophy 1 and supranuclear palsy, progressive, 1. An important gene associated with Striatonigral Degeneration is VAC14 (Vac14, PIKFYVE Complex Component), and among its related pathways/superpathways are Parkinsons Disease Pathway and Alpha-synuclein signaling. Affiliated tissues include brain, cerebellum and medulla oblongata, and related phenotype is taste/olfaction.

Wikipedia : 72 Multiple system atrophy (MSA), also known as Shy–Drager syndrome, is a rare neurodegenerative disorder... more...

Related Diseases for Striatonigral Degeneration

Diseases in the Striatonigral Degeneration family:

Striatonigral Degeneration, Infantile

Diseases related to Striatonigral Degeneration via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 48)
# Related Disease Score Top Affiliating Genes
1 multiple system atrophy 1 30.3 DRD2 SLC6A3 SNCA
2 supranuclear palsy, progressive, 1 30.1 DRD2 SLC6A3 SNCA
3 dystonia 29.6 DRD2 SLC6A3 VAC14
4 olivopontocerebellar atrophy 29.6 ATP2B3 MAP2 SNCA
5 parkinson disease, late-onset 28.6 DRD2 MAP2 SLC6A3 SNCA
6 striatonigral degeneration, infantile 12.4
7 striatonigral degeneration, childhood-onset 12.4
8 striatonigral degeneration, infantile, mitochondrial 12.2
9 familial infantile bilateral striatal necrosis 11.4
10 sporadic infantile bilateral striatal necrosis 11.4
11 classic progressive supranuclear palsy syndrome 10.3
12 neuronitis 10.2
13 multiple system atrophy, parkinsonian type 10.2
14 rem sleep behavior disorder 10.1 SLC6A3 SNCA
15 perry syndrome 10.1 SLC6A3 SNCA
16 alcohol-induced mental disorder 10.1 DRD2 SLC6A3
17 alcoholic psychosis 10.1 DRD2 SLC6A3
18 pathological gambling 10.1 DRD2 SLC6A3
19 alzheimer disease 10.1
20 dementia 10.1
21 neuroleptic malignant syndrome 10.1
22 oppositional defiant disorder 10.1 DRD2 SLC6A3
23 machado-joseph disease 10.1 SLC6A3 SNCA
24 tic disorder 10.1 DRD2 SLC6A3
25 heroin dependence 10.1 DRD2 SLC6A3
26 toxic encephalopathy 10.1 SLC6A3 SNCA
27 antisocial personality disorder 10.1 DRD2 SLC6A3
28 stuttering 10.0 DRD2 SLC6A3
29 cocaine dependence 10.0 DRD2 SLC6A3
30 conduct disorder 10.0 DRD2 SLC6A3
31 essential tremor 10.0 SLC6A3 SNCA
32 personality disorder 10.0 DRD2 SLC6A3
33 substance abuse 10.0 DRD2 SLC6A3
34 migraine with aura 10.0 DRD2 SLC6A3
35 synucleinopathy 10.0 SLC6A3 SNCA
36 eating disorder 9.9 DRD2 SLC6A3
37 motor neuron disease 9.9
38 corticobasal degeneration 9.9
39 dementia, lewy body 9.9 SLC6A3 SNCA
40 substance dependence 9.9 DRD2 SLC6A3
41 tobacco addiction 9.8 DRD2 SLC6A3
42 cocaine abuse 9.8 DRD2 SLC6A3 SNCA
43 movement disease 9.8 DRD2 SLC6A3 SNCA
44 disease of mental health 9.8 DRD2 SLC6A3 SNCA
45 restless legs syndrome 9.8 DRD2 SLC6A3 SNCA
46 gilles de la tourette syndrome 9.7 DRD2 SLC6A3
47 alcohol dependence 9.7 DRD2 SLC6A3 SNCA
48 aceruloplasminemia 9.6 ATP2B3 SNCA

Graphical network of the top 20 diseases related to Striatonigral Degeneration:



Diseases related to Striatonigral Degeneration

Symptoms & Phenotypes for Striatonigral Degeneration

MGI Mouse Phenotypes related to Striatonigral Degeneration:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 taste/olfaction MP:0005394 8.8 SNCA DRD2 SLC6A3

Drugs & Therapeutics for Striatonigral Degeneration

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Fipamezole in Neurogenic Orthostatic Hypotension Unknown status NCT00758849 Phase 2 Placebo;Fipamezole

Search NIH Clinical Center for Striatonigral Degeneration

Cochrane evidence based reviews: striatonigral degeneration

Genetic Tests for Striatonigral Degeneration

Anatomical Context for Striatonigral Degeneration

MalaCards organs/tissues related to Striatonigral Degeneration:

38
Brain, Cerebellum, Medulla Oblongata

Publications for Striatonigral Degeneration

Articles related to Striatonigral Degeneration:

(show top 50) (show all 79)
# Title Authors Year
1
Early Motor Fluctuations in a Patient with Striatonigral Degeneration. ( 28101035 )
2016
2
A rat model of striatonigral degeneration generated by simultaneous injection of 6-hydroxydopamine into the medial forebrain bundle and quinolinic Acid into the striatum. ( 25408589 )
2014
3
Intrastriatal injection of colchicine induces striatonigral degeneration in mice. ( 18564367 )
2008
4
Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy). ( 15583958 )
2005
5
Failure of caspase inhibition in the double-lesion rat model of striatonigral degeneration (multiple system atrophy). ( 15549330 )
2005
6
Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice. ( 15503195 )
2005
7
MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration. ( 14697318 )
2004
8
Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy). ( 15056471 )
2004
9
Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration. ( 15372496 )
2004
10
Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy). ( 12764627 )
2003
11
Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration. ( 11935266 )
2002
12
Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration. ( 12242540 )
2002
13
A 'single toxin-double lesion' rat model of striatonigral degeneration by intrastriatal 1-methyl-4-phenylpyridinium ion injection: a motor behavioural analysis. ( 12421620 )
2002
14
A novel grading scale for striatonigral degeneration (multiple system atrophy). ( 11956953 )
2002
15
Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. ( 11884785 )
2002
16
Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys. ( 12457736 )
2002
17
No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). ( 11226695 )
2001
18
Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration. ( 11161601 )
2001
19
FLAIR MRI of striatonigral degeneration. ( 11342686 )
2001
20
Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy). ( 10877927 )
2000
21
Toward a primate model of L-dopa-unresponsive parkinsonism mimicking striatonigral degeneration. ( 10830420 )
2000
22
Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts. ( 10658617 )
2000
23
Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). ( 10924951 )
2000
24
An early description of striatonigral degeneration. ( 10836627 )
2000
25
In vivo magnetic resonance imaging of embryonic neural grafts in a rat model of striatonigral degeneration (multiple system atrophy). ( 10913326 )
2000
26
Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. ( 10945805 )
2000
27
Loss of dopamine uptake sites and dopamine D2 receptors in striatonigral degeneration. ( 10661519 )
2000
28
Visual event-related potentials in progressive supranuclear palsy, corticobasal degeneration, striatonigral degeneration, and Parkinson's disease. ( 10896267 )
2000
29
Striatonigral degeneration with motor neuron disease. ( 10896276 )
2000
30
An early description of striatonigral degeneration. ( 10431772 )
1999
31
Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. ( 9562324 )
1998
32
Cortical and brain stem hyperexcitability in striatonigral degeneration. ( 9613764 )
1998
33
Increased basal ganglia iron in striatonigral degeneration: in vivo estimation with magnetic resonance. ( 9532280 )
1998
34
Correlative studies of MR findings with neuropathology in Shy-Drager syndrome and striatonigral degeneration. ( 9594269 )
1997
35
MRI in sporadic olivopontocerebellar atrophy and striatonigral degeneration. ( 9065575 )
1997
36
Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration. ( 9348415 )
1997
37
Urinary disturbances in striatonigral degeneration and Parkinson's disease: clinical and urodynamic aspects. ( 9251068 )
1997
38
Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. ( 8866493 )
1996
39
Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration. ( 8857740 )
1996
40
Neuroleptic malignant syndrome in striatonigral degeneration. ( 8554665 )
1995
41
Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. ( 7876847 )
1995
42
Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study. ( 7655890 )
1995
43
"Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical study. ( 7651445 )
1995
44
Striatonigral degeneration combined with olivopontocerebellar atrophy with subcortical dementia and hallucinatory state. ( 7550604 )
1995
45
Striatonigral degeneration: iron deposition in putamen correlates with the slit-like void signal of magnetic resonance imaging. ( 7533048 )
1994
46
Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. ( 8498828 )
1993
47
Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. ( 8505636 )
1993
48
Striatonigral degeneration with neurofibrillary tangles. ( 8256593 )
1993
49
Increased iron content in the putamen of patients with striatonigral degeneration. ( 1414283 )
1992
50
Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. ( 1575457 )
1992

Variations for Striatonigral Degeneration

Expression for Striatonigral Degeneration

Search GEO for disease gene expression data for Striatonigral Degeneration.

Pathways for Striatonigral Degeneration

Pathways related to Striatonigral Degeneration according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.88 SLC6A3 SNCA
2 10.13 SLC6A3 SNCA

GO Terms for Striatonigral Degeneration

Cellular components related to Striatonigral Degeneration according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuronal cell body GO:0043025 9.43 MAP2 SLC6A3 SNCA
2 axon terminus GO:0043679 9.16 DRD2 SNCA
3 axon GO:0030424 9.13 DRD2 SLC6A3 SNCA
4 intracellular membrane-bounded organelle GO:0043231 8.92 ATP2B3 NUP62 SNCA VAC14

Biological processes related to Striatonigral Degeneration according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.71 DRD2 SLC6A3 SNCA
2 locomotory behavior GO:0007626 9.56 DRD2 SLC6A3
3 excitatory postsynaptic potential GO:0060079 9.55 DRD2 SNCA
4 response to nicotine GO:0035094 9.52 DRD2 SLC6A3
5 positive regulation of multicellular organism growth GO:0040018 9.51 DRD2 SLC6A3
6 regulation of dopamine secretion GO:0014059 9.49 DRD2 SNCA
7 behavioral response to cocaine GO:0048148 9.48 DRD2 SNCA
8 response to iron ion GO:0010039 9.46 DRD2 SLC6A3
9 regulation of long-term neuronal synaptic plasticity GO:0048169 9.43 DRD2 SNCA
10 synaptic transmission, dopaminergic GO:0001963 9.4 DRD2 SNCA
11 dopamine metabolic process GO:0042417 9.37 DRD2 SNCA
12 prepulse inhibition GO:0060134 9.32 DRD2 SLC6A3
13 dopamine biosynthetic process GO:0042416 9.26 SLC6A3 SNCA
14 adenohypophysis development GO:0021984 9.16 DRD2 SLC6A3
15 dopamine uptake involved in synaptic transmission GO:0051583 8.96 SLC6A3 SNCA
16 response to cocaine GO:0042220 8.8 DRD2 SLC6A3 SNCA

Molecular functions related to Striatonigral Degeneration according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 phospholipid binding GO:0005543 9.32 NUP62 SNCA
2 drug binding GO:0008144 9.26 DRD2 SLC6A3
3 kinesin binding GO:0019894 9.16 NUP62 SNCA
4 Hsp70 protein binding GO:0030544 8.96 NUP62 SNCA
5 dopamine binding GO:0035240 8.62 DRD2 SLC6A3

Sources for Striatonigral Degeneration

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....